logo
Sign in

HAVLF Stock Price, Chart, Stats & News

HAVN Life Sciences Inc.
Save

HAVN Life Sciences Inc. (HAVLF) does not currently pay a dividend.

2,565
Market cap
Current P/E
Forward P/E

HAVLF chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Biotechnology
Industry

HAVN Life Sciences Inc. is a biotechnology firm that specializes in the research and innovation of psychotropic compounds derived from botanical and fungal organisms. The company is also dedicated to establishing standardized, quality-controlled methodologies for extracting these psychoactive molecules, with a specific focus on Psilocybe mushroom species and their key constituents such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health products utilizing unregulated ingredients.

Similar securities

Based on sector and market capitalization

Report issue